Spots Global Cancer Trial Database for losartan
Every month we try and update this database with for losartan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors | NCT03864042 | Advanced Solid ... Metastatic Mela... | losartan dextromethorpha... caffeine omeprazole midazolam rosuvastatin bupropion immed... encorafenib binimetinib modafinil | 18 Years - | Pfizer | |
| Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study | NCT03951142 | Glioblastoma Brain Metastase... | Losartan | 18 Years - | Oslo University Hospital | |
| Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | NCT01821729 | Pancreatic Canc... | FOLFIRINOX Losartan Proton Beam Rad... | 18 Years - | Massachusetts General Hospital | |
| Losartan + Sunitinib in Treatment of Osteosarcoma | NCT03900793 | Osteosarcoma | Losartan Sunitinib | 10 Years - 40 Years | University of Colorado, Denver | |
| Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma | NCT06211335 | Locally Recurre... Metastatic Head... Refractory Head... | Losartan Pembrolizumab Stereotactic Bo... | 18 Years - | University of California, Davis | |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma | NCT01199978 | Vestibular Schw... Acoustic Neurom... | Fractionated pr... Losartan | 18 Years - | Massachusetts General Hospital | |
| Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients | NCT05637216 | Radiation Induc... | Losartan 25 mil... Placebo | 18 Years - | Shaw Cancer Center | |
| Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis | NCT00879879 | Precancerous Co... | losartan | 21 Years - | University of South Florida | |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | NCT01276613 | Pancreatic Canc... | Gemcitabine Losartan | 18 Years - | M.D. Anderson Cancer Center | |
| Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma | NCT06211335 | Locally Recurre... Metastatic Head... Refractory Head... | Losartan Pembrolizumab Stereotactic Bo... | 18 Years - | University of California, Davis | |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | NCT01276613 | Pancreatic Canc... | Gemcitabine Losartan | 18 Years - | M.D. Anderson Cancer Center | |
| Losartan + Sunitinib in Treatment of Osteosarcoma | NCT03900793 | Osteosarcoma | Losartan Sunitinib | 10 Years - 40 Years | University of Colorado, Denver | |
| Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer | NCT00880386 | Dyspnea Lung Cancer Pulmonary Compl... Radiation Fibro... | Losartan | 18 Years - | University of South Florida | |
| Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER) | NCT04106856 | Borderline Rese... Locally Advance... Locally Advance... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | Hypofractionate... Losartan Losartan Potass... Quality-of-Life... Questionnaire A... | 18 Years - | University of Utah | |
| FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer | NCT05077800 | Pancreatic Aden... Pancreatic Aden... | FOLFIRNINOX Losartan 9-ING-41 | 18 Years - | Massachusetts General Hospital | |
| Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection | NCT04447235 | Cancer COVID Coronavirus Inf... | Placebo Ivermectin Losartan | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | NCT03563248 | Pancreatic Canc... | FOLFIRINOX Losartan Nivolumab SBRT Surgery | 18 Years - | Massachusetts General Hospital | |
| Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | NCT01821729 | Pancreatic Canc... | FOLFIRINOX Losartan Proton Beam Rad... | 18 Years - | Massachusetts General Hospital | |
| Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study | NCT03951142 | Glioblastoma Brain Metastase... | Losartan | 18 Years - | Oslo University Hospital | |
| GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer | NCT05861336 | Pancreatic Canc... | Losartan Gemcitabine Nab paclitaxel Stereotactic Bo... | 18 Years - 75 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | NCT03563248 | Pancreatic Canc... | FOLFIRINOX Losartan Nivolumab SBRT Surgery | 18 Years - | Massachusetts General Hospital | |
| Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer | NCT00880386 | Dyspnea Lung Cancer Pulmonary Compl... Radiation Fibro... | Losartan | 18 Years - | University of South Florida | |
| Losartan in Prevention of Radiation-Induced Heart Failure | NCT05607017 | Breast Cancer Myocardial Fibr... Radiation-Induc... | Losartan Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients | NCT05637216 | Radiation Induc... | Losartan 25 mil... Placebo | 18 Years - | Shaw Cancer Center | |
| Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients | NCT06135493 | Peripheral Neur... | Losartan | 18 Years - | Future University in Egypt | |
| Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection | NCT04447235 | Cancer COVID Coronavirus Inf... | Placebo Ivermectin Losartan | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma | NCT01805453 | Newly-diagnosed... | Losartan Placebo | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer | NCT01281787 | Lung Cancer Atrial Fibrilla... | Metoprolol Losartan | 18 Years - | European Institute of Oncology | |
| GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer | NCT05861336 | Pancreatic Canc... | Losartan Gemcitabine Nab paclitaxel Stereotactic Bo... | 18 Years - 75 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
